February 15, 2013






HOUSE BILL No. 1524

_____


DIGEST OF HB 1524 (Updated February 13, 2013 4:09 pm - DI 69)



Citations Affected: IC 4-6; IC 6-2.5; IC 9-13; IC 16-31; IC 20-28; IC 22-15; IC 24-5; IC 25-1; IC 25-26; IC 32-30; IC 34-24; IC 35-31.5; IC 35-45; IC 35-46; IC 35-48.

Synopsis: Synthetic drugs. Permits the attorney general to issue a civil investigative demand to obtain immediate access to records relating to the sale of synthetic drugs. Provides that the department of state revenue may revoke a retail merchant certificate if the holder commits certain violations relating to synthetic drugs. Provides that a person may be intoxicated if the person consumes any substance resulting in impairment, with certain exceptions. Defines certain acts in relation to synthetic drugs as deceptive acts. Permits the board of pharmacy, on its own initiative or upon formal request from the state police department, the federal Drug Enforcement Administration, or a poison control center, to adopt an emergency rule declaring certain substances to be synthetic drugs. Permits the attorney general to bring an action to abate a nuisance created in connection with the sale of synthetic drugs. Authorizes the seizure of certain property used in connection with dealing in synthetic drugs. Defines additional substances as synthetic drugs, and makes the sale of a synthetic drug lookalike substance a criminal offense. Adds dealing in synthetic drugs to the list of racketeering offenses. Makes conforming amendments.

Effective: Upon passage.





Smith M, Davisson, Austin




    January 22, 2013, read first time and referred to Committee on Courts and Criminal Code.
    February 14, 2013, amended, reported _ Do Pass.







February 15, 2013

First Regular Session 118th General Assembly (2013)


PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana Constitution) is being amended, the text of the existing provision will appear in this style type, additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional provision adopted), the text of the new provision will appear in this style type. Also, the word NEW will appear in that style type in the introductory clause of each SECTION that adds a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts between statutes enacted by the 2012 Regular Session of the General Assembly.

HOUSE BILL No. 1524



    A BILL FOR AN ACT to amend the Indiana Code concerning criminal law and procedure.

Be it enacted by the General Assembly of the State of Indiana:

SOURCE: IC 4-6-3-4; (13)HB1524.1.1. -->     SECTION 1. IC 4-6-3-4 IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 4. An investigative demand shall contain the following:
        (1) A general description of the subject matter being investigated and a statement of the applicable provisions of law.
        (2) The date, time, and place at which the person is to appear, answer written interrogatories, or produce documentary material or other tangible items. The date shall not be less than ten (10) days from the date of service of the demand. However, the attorney general may demand and obtain immediate access to records and materials if access is necessary for purposes of investigating alleged violations relating to sales or solicited sales of a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5).
        (3) Where the production of documents or other tangible items is required, a description of those documents or items by class with

sufficient clarity so that they might be reasonably identified.

SOURCE: IC 6-2.5-8-7; (13)HB1524.1.2. -->     SECTION 2. IC 6-2.5-8-7, AS AMENDED BY P.L.78-2012, SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 7. (a) The department may, for good cause, revoke a certificate issued under section 1, 3, or 4 of this chapter. However, the department must give the certificate holder at least five (5) days notice before it revokes the certificate under this subsection. Good cause for revocation may include the following:
        (1) Sale or solicitation of a sale involving a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5).
        (2) Failure to collect sales tax on a sale involving a synthetic drug or a synthetic drug lookalike substance.
If the department gives notice of an intent to revoke based on an alleged violation of subdivision (1) or (2), the department shall hold a public hearing to determine whether good cause exists. If the department finds in a public hearing by a preponderance of the evidence that a person has committed a violation described in subdivision (1) or (2), the department shall suspend the person's registered retail merchant certificate subject to the requirements and prohibitions contained in subsection (i).

    (b) The department shall revoke a certificate issued under section 1, 3, or 4 of this chapter if, for a period of three (3) years, the certificate holder fails to:
        (1) file the returns required by IC 6-2.5-6-1; or
        (2) report the collection of any state gross retail or use tax on the returns filed under IC 6-2.5-6-1.
However, the department must give the certificate holder at least five (5) days notice before it revokes the certificate.
    (c) The department may, for good cause, revoke a certificate issued under section 1 of this chapter after at least five (5) days notice to the certificate holder if:
        (1) the certificate holder is subject to an innkeeper's tax under IC 6-9; and
        (2) a board, bureau, or commission established under IC 6-9 files a written statement with the department.
    (d) The statement filed under subsection (c) must state that:
        (1) information obtained by the board, bureau, or commission under IC 6-8.1-7-1 indicates that the certificate holder has not complied with IC 6-9; and
        (2) the board, bureau, or commission has determined that significant harm will result to the county from the certificate

holder's failure to comply with IC 6-9.
    (e) The department shall revoke or suspend a certificate issued under section 1 of this chapter after at least five (5) days notice to the certificate holder if:
        (1) the certificate holder owes taxes, penalties, fines, interest, or costs due under IC 6-1.1 that remain unpaid at least sixty (60) days after the due date under IC 6-1.1; and
        (2) the treasurer of the county to which the taxes are due requests the department to revoke or suspend the certificate.
    (f) The department shall reinstate a certificate suspended under subsection (e) if the taxes and any penalties due under IC 6-1.1 are paid or the county treasurer requests the department to reinstate the certificate because an agreement for the payment of taxes and any penalties due under IC 6-1.1 has been reached to the satisfaction of the county treasurer.
    (g) The department shall revoke a certificate issued under section 1 of this chapter after at least five (5) days notice to the certificate holder if the department finds in a public hearing by a preponderance of the evidence that the certificate holder has violated IC 35-45-5-3, IC 35-45-5-3.5, or IC 35-45-5-4.
    (h) If a person makes a payment for the certificate under section 1 or 3 of this chapter with a check, credit card, debit card, or electronic funds transfer, and the department is unable to obtain payment of the check, credit card, debit card, or electronic funds transfer for its full face amount when the check, credit card, debit card, or electronic funds transfer is presented for payment through normal banking channels, the department shall notify the person by mail that the check, credit card, debit card, or electronic funds transfer was not honored and that the person has five (5) days after the notice is mailed to pay the fee in cash, by certified check, or other guaranteed payment. If the person fails to make the payment within the five (5) day period, the department shall revoke the certificate.
    (i) If the department finds in a public hearing by a preponderance of the evidence that a person has been convicted of violating IC 35-48-4-10 a conviction or judgment for a violation of IC 35-48-4-10.5 and the conviction or violation involved the sale of or the offer to sell, in the normal course of business, a synthetic drug or a synthetic drug lookalike substance by a retail merchant in a place of business for which the retail merchant has been issued a registered retail merchant certificate under section 1 of this chapter, the department:
        (1) shall suspend the registered retail merchant certificate for the

place of business for one (1) year; and
        (2) may not issue another retail merchant certificate under section 1 of this chapter for one (1) year to any person:
            (A) that:
                (i) applied for; or
                (ii) made a retail transaction under;
            the retail merchant certificate suspended under subdivision (1); or
            (B) that:
                (i) owned or co-owned, directly or indirectly; or
                (ii) was an officer, a director, a manager, or a partner of;
            the retail merchant that was issued the retail merchant certificate suspended under subdivision (1).

SOURCE: IC 9-13-2-86; (13)HB1524.1.3. -->     SECTION 3. IC 9-13-2-86, AS AMENDED BY P.L.151-2006, SECTION 4, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 86. "Intoxicated" means under the influence of:
        (1) alcohol;
        (2) a controlled substance (as defined in IC 35-48-1);
        (3) a drug other than alcohol or a controlled substance;
        (4) a substance described in IC 35-46-6-2 or IC 35-46-6-3; or
        (5) a combination of substances described in subdivisions (1) through (4); or
        (6) any other substance, not including food and food ingredients (as defined in IC 6-2.5-1-20), tobacco, or a dietary supplement (as defined in IC 6-2.5-1-16);

so that there is an impaired condition of thought and action and the loss of normal control of a person's faculties.
SOURCE: IC 16-31-3-14.5; (13)HB1524.1.4. -->     SECTION 4. IC 16-31-3-14.5, AS AMENDED BY P.L.77-2012, SECTION 35, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 14.5. The department of homeland security may issue an order under IC 4-21.5-3-6 to deny an applicant's request for certification or licensure or permanently revoke a certificate or license under procedures provided by section 14 of this chapter if the individual who holds the certificate or license issued under this title is convicted of any of the following:
        (1) Dealing in or manufacturing cocaine or a narcotic drug under IC 35-48-4-1.
        (2) Dealing in methamphetamine under IC 35-48-4-1.1.
        (3) Dealing in a schedule I, II, or III controlled substance under IC 35-48-4-2.
        (4) Dealing in a schedule IV controlled substance under

IC 35-48-4-3.
        (5) Dealing in a schedule V controlled substance under IC 35-48-4-4.
        (6) Dealing in a substance represented to be a controlled substance under IC 35-48-4-4.5.
        (7) Knowingly or intentionally manufacturing, advertising, distributing, or possessing with intent to manufacture, advertise, or distribute a substance represented to be a controlled substance under IC 35-48-4-4.6.
        (8) Dealing in a counterfeit substance under IC 35-48-4-5.
        (9) Dealing in marijuana, hash oil, hashish, or salvia or a synthetic drug under IC 35-48-4-10(b).
         (10) Dealing in a synthetic drug or synthetic drug lookalike substance under IC 35-48-4-10.5.
        (10) (11) Conspiracy under IC 35-41-5-2 to commit an offense listed in subdivisions (1) through (9) this section.
        (11) (12) Attempt under IC 35-41-5-1 to commit an offense listed in subdivisions (1) through (9) this section.
        (12) (13) A crime of violence (as defined in IC 35-50-1-2(a)).
        (13) (14) An offense in any other jurisdiction in which the elements of the offense for which the conviction was entered are substantially similar to the elements of an offense described under subdivisions (1) through (12) this section.

SOURCE: IC 20-28-5-8; (13)HB1524.1.5. -->     SECTION 5. IC 20-28-5-8, AS AMENDED BY P.L.78-2012, SECTION 5, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 8. (a) This section applies when a prosecuting attorney knows that a licensed employee of a public school or a nonpublic school has been convicted of an offense listed in subsection (c). The prosecuting attorney shall immediately give written notice of the conviction to the following:
        (1) The state superintendent.
        (2) Except as provided in subdivision (3), the superintendent of the school corporation that employs the licensed employee or the equivalent authority if a nonpublic school employs the licensed employee.
        (3) The presiding officer of the governing body of the school corporation that employs the licensed employee, if the convicted licensed employee is the superintendent of the school corporation.
    (b) The superintendent of a school corporation, presiding officer of the governing body, or equivalent authority for a nonpublic school shall immediately notify the state superintendent when the individual knows that a current or former licensed employee of the public school or

nonpublic school has been convicted of an offense listed in subsection (c), or when the governing body or equivalent authority for a nonpublic school takes any final action in relation to an employee who engaged in any offense listed in subsection (c).
    (c) The department, after holding a hearing on the matter, shall permanently revoke the license of a person who is known by the department to have been convicted of any of the following felonies:
        (1) Kidnapping (IC 35-42-3-2).
        (2) Criminal confinement (IC 35-42-3-3).
        (3) Rape (IC 35-42-4-1).
        (4) Criminal deviate conduct (IC 35-42-4-2).
        (5) Child molesting (IC 35-42-4-3).
        (6) Child exploitation (IC 35-42-4-4(b)).
        (7) Vicarious sexual gratification (IC 35-42-4-5).
        (8) Child solicitation (IC 35-42-4-6).
        (9) Child seduction (IC 35-42-4-7).
        (10) Sexual misconduct with a minor (IC 35-42-4-9).
        (11) Incest (IC 35-46-1-3).
        (12) Dealing in or manufacturing cocaine or a narcotic drug (IC 35-48-4-1).
        (13) Dealing in methamphetamine (IC 35-48-4-1.1).
        (14) Dealing in a schedule I, II, or III controlled substance (IC 35-48-4-2).
        (15) Dealing in a schedule IV controlled substance (IC 35-48-4-3).
        (16) Dealing in a schedule V controlled substance (IC 35-48-4-4).
        (17) Dealing in a counterfeit substance (IC 35-48-4-5).
        (18) Dealing in marijuana, hash oil, hashish, or salvia or a synthetic drug (IC 35-48-4-10(b)).
         (19) Dealing in a synthetic drug or synthetic drug lookalike substance (IC 35-48-4-10.5).
        (19) (20) Possession of child pornography (IC 35-42-4-4(c)).
        (20) (21) Homicide (IC 35-42-1).
        (21) (22) Voluntary manslaughter (IC 35-42-1-3).
        (22) (23) Reckless homicide (IC 35-42-1-5).
        (23) (24) Battery as any of the following:
            (A) A Class A felony (IC 35-42-2-1(a)(5)).
            (B) A Class B felony (IC 35-42-2-1(a)(4)).
            (C) A Class C felony (IC 35-42-2-1(a)(3)).
        (24) (25) Aggravated battery (IC 35-42-2-1.5).
        (25) (26) Robbery (IC 35-42-5-1).
        (26) (27) Carjacking (IC 35-42-5-2).


        (27) (28) Arson as a Class A felony or a Class B felony (IC 35-43-1-1(a)).
        (28) (29) Burglary as a Class A felony or a Class B felony (IC 35-43-2-1).
        (29) (30) Attempt under IC 35-41-5-1 to commit an offense listed in subdivisions (1) through (28) this subsection.
        (30) (31) Conspiracy under IC 35-41-5-2 to commit an offense listed in subdivisions (1) through (28) this subsection.
    (d) The department, after holding a hearing on the matter, shall permanently revoke the license of a person who is known by the department to have been convicted of a federal offense or an offense in another state that is comparable to a felony listed in subsection (c).
    (e) A license may be suspended by the state superintendent as specified in IC 20-28-7.5.
    (f) The department shall develop a data base of information on school corporation employees who have been reported to the department under this section.
SOURCE: IC 22-15-5-16; (13)HB1524.1.6. -->     SECTION 6. IC 22-15-5-16, AS AMENDED BY P.L.78-2012, SECTION 6, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 16. (a) A practitioner shall comply with the standards established under this licensing program. A practitioner is subject to the exercise of the disciplinary sanctions under subsection (b) if the department finds that a practitioner has:
        (1) engaged in or knowingly cooperated in fraud or material deception in order to obtain a license to practice, including cheating on a licensing examination;
        (2) engaged in fraud or material deception in the course of professional services or activities;
        (3) advertised services or goods in a false or misleading manner;
        (4) falsified or knowingly allowed another person to falsify attendance records or certificates of completion of continuing education courses provided under this chapter;
        (5) been convicted of a crime that has a direct bearing on the practitioner's ability to continue to practice competently;
        (6) knowingly violated a state statute or rule or federal statute or regulation regulating the profession for which the practitioner is licensed;
        (7) continued to practice although the practitioner has become unfit to practice due to:
            (A) professional incompetence;
            (B) failure to keep abreast of current professional theory or practice;
            (C) physical or mental disability; or
            (D) addiction to, abuse of, or severe dependency on alcohol or other drugs that endanger the public by impairing a practitioner's ability to practice safely;
        (8) engaged in a course of lewd or immoral conduct in connection with the delivery of services to the public;
        (9) allowed the practitioner's name or a license issued under this chapter to be used in connection with an individual or business who renders services beyond the scope of that individual's or business's training, experience, or competence;
        (10) had disciplinary action taken against the practitioner or the practitioner's license to practice in another state or jurisdiction on grounds similar to those under this chapter;
        (11) assisted another person in committing an act that would constitute a ground for disciplinary sanction under this chapter; or
        (12) allowed a license issued by the department to be:
            (A) used by another person; or
            (B) displayed to the public when the license has expired, is inactive, is invalid, or has been revoked or suspended.
For purposes of subdivision (10), a certified copy of a record of disciplinary action constitutes prima facie evidence of a disciplinary action in another jurisdiction.
    (b) The department may impose one (1) or more of the following sanctions if the department finds that a practitioner is subject to disciplinary sanctions under subsection (a):
        (1) Permanent revocation of a practitioner's license.
        (2) Suspension of a practitioner's license.
        (3) Censure of a practitioner.
        (4) Issuance of a letter of reprimand.
        (5) Assess a civil penalty against the practitioner in accordance with the following:
            (A) The civil penalty may not be more than one thousand dollars ($1,000) for each violation listed in subsection (a), except for a finding of incompetency due to a physical or mental disability.
            (B) When imposing a civil penalty, the department shall consider a practitioner's ability to pay the amount assessed. If the practitioner fails to pay the civil penalty within the time specified by the department, the department may suspend the practitioner's license without additional proceedings. However, a suspension may not be imposed if the sole basis for the

suspension is the practitioner's inability to pay a civil penalty.
        (6) Place a practitioner on probation status and require the practitioner to:
            (A) report regularly to the department upon the matters that are the basis of probation;
            (B) limit practice to those areas prescribed by the department;
            (C) continue or renew professional education approved by the department until a satisfactory degree of skill has been attained in those areas that are the basis of the probation; or
            (D) perform or refrain from performing any acts, including community restitution or service without compensation, that the department considers appropriate to the public interest or to the rehabilitation or treatment of the practitioner.
        The department may withdraw or modify this probation if the department finds after a hearing that the deficiency that required disciplinary action has been remedied or that changed circumstances warrant a modification of the order.
    (c) If an applicant or a practitioner has engaged in or knowingly cooperated in fraud or material deception to obtain a license to practice, including cheating on the licensing examination, the department may rescind the license if it has been granted, void the examination or other fraudulent or deceptive material, and prohibit the applicant from reapplying for the license for a length of time established by the department.
    (d) The department may deny licensure to an applicant who has had disciplinary action taken against the applicant or the applicant's license to practice in another state or jurisdiction or who has practiced without a license in violation of the law. A certified copy of the record of disciplinary action is conclusive evidence of the other jurisdiction's disciplinary action.
    (e) The department may order a practitioner to submit to a reasonable physical or mental examination if the practitioner's physical or mental capacity to practice safely and competently is at issue in a disciplinary proceeding. Failure to comply with a department order to submit to a physical or mental examination makes a practitioner liable to temporary suspension under subsection (j).
    (f) Except as provided under subsection (g) or (h), a license may not be denied, revoked, or suspended because the applicant or holder has been convicted of an offense. The acts from which the applicant's or holder's conviction resulted may, however, be considered as to whether the applicant or holder should be entrusted to serve the public in a specific capacity.


    (g) The department may deny, suspend, or revoke a license issued under this chapter if the individual who holds the license is convicted of any of the following:
        (1) Possession of cocaine or a narcotic drug under IC 35-48-4-6.
        (2) Possession of methamphetamine under IC 35-48-4-6.1.
        (3) Possession of a controlled substance under IC 35-48-4-7(a).
        (4) Fraudulently obtaining a controlled substance under IC 35-48-4-7(b).
        (5) Manufacture of paraphernalia as a Class D felony under IC 35-48-4-8.1(b).
        (6) Dealing in paraphernalia as a Class D felony under IC 35-48-4-8.5(b).
        (7) Possession of paraphernalia as a Class D felony under IC 35-48-4-8.3(b).
        (8) Possession of marijuana, hash oil, hashish, salvia, or a synthetic drug as a Class D felony under IC 35-48-4-11.
        (9) Maintaining a common nuisance under IC 35-48-4-13.
        (10) An offense relating to registration, labeling, and prescription forms under IC 35-48-4-14.
        (11) Conspiracy under IC 35-41-5-2 to commit an offense listed in subdivisions (1) through (10).
        (12) Attempt under IC 35-41-5-1 to commit an offense listed in subdivisions (1) through (10).
        (13) An offense in any other jurisdiction in which the elements of the offense for which the conviction was entered are substantially similar to the elements of an offense described in subdivisions (1) through (12).
    (h) The department shall deny, revoke, or suspend a license issued under this chapter if the individual who holds the license is convicted of any of the following:
        (1) Dealing in cocaine or a narcotic drug under IC 35-48-4-1.
        (2) Dealing in methamphetamine under IC 35-48-4-1.1.
        (3) Dealing in a schedule I, II, or III controlled substance under IC 35-48-4-2.
        (4) Dealing in a schedule IV controlled substance under IC 35-48-4-3.
        (5) Dealing in a schedule V controlled substance under IC 35-48-4-4.
        (6) Dealing in a substance represented to be a controlled substance under IC 35-48-4-4.5.
        (7) Knowingly or intentionally manufacturing, advertising, distributing, or possessing with intent to manufacture, advertise,

or distribute a substance represented to be a controlled substance under IC 35-48-4-4.6.
        (8) Dealing in a counterfeit substance under IC 35-48-4-5.
        (9) Dealing in marijuana, hash oil, hashish, or salvia or a synthetic drug under IC 35-48-4-10(b).
         (10) Dealing in a synthetic drug or synthetic drug lookalike substance under IC 35-48-4-10.5.
        (10) (11) Conspiracy under IC 35-41-5-2 to commit an offense listed in subdivisions (1) through (9). this subsection.
        (11) (12) Attempt under IC 35-41-5-1 to commit an offense listed in subdivisions (1) through (9) this subsection.
        (12) (13) An offense in any other jurisdiction in which the elements of the offense for which the conviction was entered are substantially similar to the elements of an offense described in subdivisions (1) through (11) this subsection.
        (13) (14) A violation of any federal or state drug law or rule related to wholesale legend drug distributors licensed under IC 25-26-14.
    (i) A decision of the department under subsections (b) through (h) may be appealed to the commission under IC 4-21.5-3-7.
    (j) The department may temporarily suspend a practitioner's license under IC 4-21.5-4 before a final adjudication or during the appeals process if the department finds that a practitioner represents a clear and immediate danger to the public's health, safety, or property if the practitioner is allowed to continue to practice.
    (k) On receipt of a complaint or an information alleging that a person licensed under this chapter has engaged in or is engaging in a practice that jeopardizes the public health, safety, or welfare, the department shall initiate an investigation against the person.
    (l) Any complaint filed with the office of the attorney general alleging a violation of this licensing program shall be referred to the department for summary review and for its general information and any authorized action at the time of the filing.
    (m) The department shall conduct a fact finding investigation as the department considers proper in relation to the complaint.
    (n) The department may reinstate a license that has been suspended under this section if, after a hearing, the department is satisfied that the applicant is able to practice with reasonable skill, safety, and competency to the public. As a condition of reinstatement, the department may impose disciplinary or corrective measures authorized under this chapter.
    (o) The department may not reinstate a license that has been

revoked under this chapter. An individual whose license has been revoked under this chapter may not apply for a new license until seven (7) years after the date of revocation.
    (p) The department shall seek to achieve consistency in the application of sanctions authorized in this chapter. Significant departures from prior decisions involving similar conduct must be explained in the department's findings or orders.
    (q) A practitioner may petition the department to accept the surrender of the practitioner's license instead of having a hearing before the commission. The practitioner may not surrender the practitioner's license without the written approval of the department, and the department may impose any conditions appropriate to the surrender or reinstatement of a surrendered license.
    (r) A practitioner who has been subjected to disciplinary sanctions may be required by the commission to pay the costs of the proceeding. The practitioner's ability to pay shall be considered when costs are assessed. If the practitioner fails to pay the costs, a suspension may not be imposed solely upon the practitioner's inability to pay the amount assessed. The costs are limited to costs for the following:
        (1) Court reporters.
        (2) Transcripts.
        (3) Certification of documents.
        (4) Photo duplication.
        (5) Witness attendance and mileage fees.
        (6) Postage.
        (7) Expert witnesses.
        (8) Depositions.
        (9) Notarizations.

SOURCE: IC 24-5-0.5-3; (13)HB1524.1.7. -->     SECTION 7. IC 24-5-0.5-3, AS AMENDED BY P.L.226-2011, SECTION 14, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 3. (a) The following acts, and the following representations as to the subject matter of a consumer transaction, made orally, in writing, or by electronic communication, by a supplier, are deceptive acts:
        (1) That such subject of a consumer transaction has sponsorship, approval, performance, characteristics, accessories, uses, or benefits it does not have which the supplier knows or should reasonably know it does not have.
        (2) That such subject of a consumer transaction is of a particular standard, quality, grade, style, or model, if it is not and if the supplier knows or should reasonably know that it is not.
        (3) That such subject of a consumer transaction is new or unused,

if it is not and if the supplier knows or should reasonably know that it is not.
        (4) That such subject of a consumer transaction will be supplied to the public in greater quantity than the supplier intends or reasonably expects.
        (5) That replacement or repair constituting the subject of a consumer transaction is needed, if it is not and if the supplier knows or should reasonably know that it is not.
        (6) That a specific price advantage exists as to such subject of a consumer transaction, if it does not and if the supplier knows or should reasonably know that it does not.
        (7) That the supplier has a sponsorship, approval, or affiliation in such consumer transaction the supplier does not have, and which the supplier knows or should reasonably know that the supplier does not have.
        (8) That such consumer transaction involves or does not involve a warranty, a disclaimer of warranties, or other rights, remedies, or obligations, if the representation is false and if the supplier knows or should reasonably know that the representation is false.
        (9) That the consumer will receive a rebate, discount, or other benefit as an inducement for entering into a sale or lease in return for giving the supplier the names of prospective consumers or otherwise helping the supplier to enter into other consumer transactions, if earning the benefit, rebate, or discount is contingent upon the occurrence of an event subsequent to the time the consumer agrees to the purchase or lease.
        (10) That the supplier is able to deliver or complete the subject of the consumer transaction within a stated period of time, when the supplier knows or should reasonably know the supplier could not. If no time period has been stated by the supplier, there is a presumption that the supplier has represented that the supplier will deliver or complete the subject of the consumer transaction within a reasonable time, according to the course of dealing or the usage of the trade.
        (11) That the consumer will be able to purchase the subject of the consumer transaction as advertised by the supplier, if the supplier does not intend to sell it.
        (12) That the replacement or repair constituting the subject of a consumer transaction can be made by the supplier for the estimate the supplier gives a customer for the replacement or repair, if the specified work is completed and:
            (A) the cost exceeds the estimate by an amount equal to or

greater than ten percent (10%) of the estimate;
            (B) the supplier did not obtain written permission from the customer to authorize the supplier to complete the work even if the cost would exceed the amounts specified in clause (A);
            (C) the total cost for services and parts for a single transaction is more than seven hundred fifty dollars ($750); and
            (D) the supplier knew or reasonably should have known that the cost would exceed the estimate in the amounts specified in clause (A).
        (13) That the replacement or repair constituting the subject of a consumer transaction is needed, and that the supplier disposes of the part repaired or replaced earlier than seventy-two (72) hours after both:
            (A) the customer has been notified that the work has been completed; and
            (B) the part repaired or replaced has been made available for examination upon the request of the customer.
        (14) Engaging in the replacement or repair of the subject of a consumer transaction if the consumer has not authorized the replacement or repair, and if the supplier knows or should reasonably know that it is not authorized.
        (15) The act of misrepresenting the geographic location of the supplier by listing a fictitious business name or an assumed business name (as described in IC 23-15-1) in a local telephone directory if:
            (A) the name misrepresents the supplier's geographic location;
            (B) the listing fails to identify the locality and state of the supplier's business;
            (C) calls to the local telephone number are routinely forwarded or otherwise transferred to a supplier's business location that is outside the calling area covered by the local telephone directory; and
            (D) the supplier's business location is located in a county that is not contiguous to a county in the calling area covered by the local telephone directory.
        (16) The act of listing a fictitious business name or assumed business name (as described in IC 23-15-1) in a directory assistance database if:
            (A) the name misrepresents the supplier's geographic location;
            (B) calls to the local telephone number are routinely forwarded or otherwise transferred to a supplier's business location that is outside the local calling area; and


            (C) the supplier's business location is located in a county that is not contiguous to a county in the local calling area.
        (17) The violation by a supplier of IC 24-3-4 concerning cigarettes for import or export.
        (18) The act of a supplier in knowingly selling or reselling a product to a consumer if the product has been recalled, whether by the order of a court or a regulatory body, or voluntarily by the manufacturer, distributor, or retailer, unless the product has been repaired or modified to correct the defect that was the subject of the recall.
        (19) The violation by a supplier of 47 U.S.C. 227, including any rules or regulations issued under 47 U.S.C. 227.
        (20) The violation by a supplier of the federal Fair Debt Collection Practices Act (15 U.S.C. 1692 et seq.), including any rules or regulations issued under the federal Fair Debt Collection Practices Act (15 U.S.C. 1692 et seq.).
        (21) A violation of IC 24-5-7 (concerning health spa services), as set forth in IC 24-5-7-17.
        (22) A violation of IC 24-5-8 (concerning business opportunity transactions), as set forth in IC 24-5-8-20.
        (23) A violation of IC 24-5-10 (concerning home consumer transactions), as set forth in IC 24-5-10-18.
        (24) A violation of IC 24-5-11 (concerning home improvement contracts), as set forth in IC 24-5-11-14.
        (25) A violation of IC 24-5-12 (concerning telephone solicitations), as set forth in IC 24-5-12-23.
        (26) A violation of IC 24-5-13.5 (concerning buyback motor vehicles), as set forth in IC 24-5-13.5-14.
        (27) A violation of IC 24-5-14 (concerning automatic dialing-announcing devices), as set forth in IC 24-5-14-13.
        (28) A violation of IC 24-5-15 (concerning credit services organizations), as set forth in IC 24-5-15-11.
        (29) A violation of IC 24-5-16 (concerning unlawful motor vehicle subleasing), as set forth in IC 24-5-16-18.
        (30) A violation of IC 24-5-17 (concerning environmental marketing claims), as set forth in IC 24-5-17-14.
        (31) A violation of IC 24-5-19 (concerning deceptive commercial solicitation), as set forth in IC 24-5-19-11.
        (32) A violation of IC 24-5-21 (concerning prescription drug discount cards), as set forth in IC 24-5-21-7.
        (33) A violation of IC 24-5-23.5-7 (concerning real estate appraisals), as set forth in IC 24-5-23.5-9.
        (34) A violation of IC 24-5-26 (concerning identity theft), as set forth in IC 24-5-26-3.
        (35) A violation of IC 24-5.5 (concerning mortgage rescue fraud), as set forth in IC 24-5.5-6-1.
        (36) A violation of IC 24-8 (concerning promotional gifts and contests), as set forth in IC 24-8-6-3.
    (b) Any representations on or within a product or its packaging or in advertising or promotional materials which would constitute a deceptive act shall be the deceptive act both of the supplier who places such representation thereon or therein, or who authored such materials, and such other suppliers who shall state orally or in writing that such representation is true if such other supplier shall know or have reason to know that such representation was false.
    (c) If a supplier shows by a preponderance of the evidence that an act resulted from a bona fide error notwithstanding the maintenance of procedures reasonably adopted to avoid the error, such act shall not be deceptive within the meaning of this chapter.
    (d) It shall be a defense to any action brought under this chapter that the representation constituting an alleged deceptive act was one made in good faith by the supplier without knowledge of its falsity and in reliance upon the oral or written representations of the manufacturer, the person from whom the supplier acquired the product, any testing organization, or any other person provided that the source thereof is disclosed to the consumer.
    (e) For purposes of subsection (a)(12), a supplier that provides estimates before performing repair or replacement work for a customer shall give the customer a written estimate itemizing as closely as possible the price for labor and parts necessary for the specific job before commencing the work.
    (f) For purposes of subsection (a)(15) and (a)(16), a telephone company or other provider of a telephone directory or directory assistance service or its officer or agent is immune from liability for publishing the listing of a fictitious business name or assumed business name of a supplier in its directory or directory assistance database unless the telephone company or other provider of a telephone directory or directory assistance service is the same person as the supplier who has committed the deceptive act.
    (g) For purposes of subsection (a)(18), it is an affirmative defense to any action brought under this chapter that the product has been altered by a person other than the defendant to render the product completely incapable of serving its original purpose.
     (h) This subsection applies only to consumer transactions or

solicited consumer transactions relating to synthetic drugs (as defined in IC 35-31.5-2-321) or synthetic drug lookalike substances (as defined in IC 35-31.5-2-321.5). It is a deceptive act for a supplier to make, orally, in writing, by implication, or by electronic communication, any of the representations listed in subsection (a) in relation to the subject matter of a consumer transaction.

SOURCE: IC 24-5-0.5-4; (13)HB1524.1.8. -->     SECTION 8. IC 24-5-0.5-4, AS AMENDED BY P.L.226-2011, SECTION 15, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 4. (a) A person relying upon an uncured or incurable deceptive act may bring an action for the damages actually suffered as a consumer as a result of the deceptive act or five hundred dollars ($500), whichever is greater. The court may increase damages for a willful deceptive act in an amount that does not exceed the greater of:
        (1) three (3) times the actual damages of the consumer suffering the loss; or
        (2) one thousand dollars ($1,000).
Except as provided in subsection (j), the court may award reasonable attorney fees to the party that prevails in an action under this subsection. This subsection does not apply to a consumer transaction in real property, including a claim or action involving a construction defect (as defined in IC 32-27-3-1(5)) brought against a construction professional (as defined in IC 32-27-3-1(4)), except for purchases of time shares and camping club memberships. This subsection does not apply with respect to a deceptive act described in section 3(a)(20) of this chapter. This subsection also does not apply to a violation of IC 24-4.7, IC 24-5-12, or IC 24-5-14. Actual damages awarded to a person under this section have priority over any civil penalty imposed under this chapter.
    (b) Any person who is entitled to bring an action under subsection (a) on the person's own behalf against a supplier for damages for a deceptive act may bring a class action against such supplier on behalf of any class of persons of which that person is a member and which has been damaged by such deceptive act, subject to and under the Indiana Rules of Trial Procedure governing class actions, except as herein expressly provided. Except as provided in subsection (j), the court may award reasonable attorney fees to the party that prevails in a class action under this subsection, provided that such fee shall be determined by the amount of time reasonably expended by the attorney and not by the amount of the judgment, although the contingency of the fee may be considered. Except in the case of an extension of time granted by the attorney general under IC 24-10-2-2(b) in an action subject to IC 24-10,

any money or other property recovered in a class action under this subsection which cannot, with due diligence, be restored to consumers within one (1) year after the judgment becomes final shall be returned to the party depositing the same. This subsection does not apply to a consumer transaction in real property, except for purchases of time shares and camping club memberships. This subsection does not apply with respect to a deceptive act described in section 3(a)(20) of this chapter. Actual damages awarded to a class have priority over any civil penalty imposed under this chapter.
    (c) The attorney general may bring an action to enjoin a deceptive act, including a deceptive act described in section 3(a)(20) of this chapter, notwithstanding subsections (a) and (b). However, the attorney general may seek to enjoin patterns of incurable deceptive acts with respect to consumer transactions in real property. In addition, the court may:
        (1) issue an injunction;
        (2) order the supplier to make payment of the money unlawfully received from the aggrieved consumers to be held in escrow for distribution to aggrieved consumers;
        (3) order the supplier to pay to the state the reasonable costs of the attorney general's investigation and prosecution related to the action; and
        (4) provide for the appointment of a receiver; and
        (5) order the department of state revenue to suspend the supplier's registered retail merchant certificate, subject to the requirements and prohibitions contained in IC 6-2.5-8-7(i), if the court finds that a violation of this chapter involved the sale or solicited sale of a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5).
    (d) In an action under subsection (a), (b), or (c), the court may void or limit the application of contracts or clauses resulting from deceptive acts and order restitution to be paid to aggrieved consumers.
    (e) In any action under subsection (a) or (b), upon the filing of the complaint or on the appearance of any defendant, claimant, or any other party, or at any later time, the trial court, the supreme court, or the court of appeals may require the plaintiff, defendant, claimant, or any other party or parties to give security, or additional security, in such sum as the court shall direct to pay all costs, expenses, and disbursements that shall be awarded against that party or which that party may be directed to pay by any interlocutory order by the final judgment or on appeal.


    (f) Any person who violates the terms of an injunction issued under subsection (c) shall forfeit and pay to the state a civil penalty of not more than fifteen thousand dollars ($15,000) per violation. For the purposes of this section, the court issuing an injunction shall retain jurisdiction, the cause shall be continued, and the attorney general acting in the name of the state may petition for recovery of civil penalties. Whenever the court determines that an injunction issued under subsection (c) has been violated, the court shall award reasonable costs to the state.
    (g) If a court finds any person has knowingly violated section 3 or 10 of this chapter, other than section 3(a)(19) or 3(a)(20) of this chapter, the attorney general, in an action pursuant to subsection (c), may recover from the person on behalf of the state a civil penalty of a fine not exceeding five thousand dollars ($5,000) per violation.
    (h) If a court finds that a person has violated section 3(a)(19) of this chapter, the attorney general, in an action under subsection (c), may recover from the person on behalf of the state a civil penalty as follows:
        (1) For a knowing or intentional violation, one thousand five hundred dollars ($1,500).
        (2) For a violation other than a knowing or intentional violation, five hundred dollars ($500).
A civil penalty recovered under this subsection shall be deposited in the consumer protection division telephone solicitation fund established by IC 24-4.7-3-6 to be used for the administration and enforcement of section 3(a)(19) of this chapter.
    (i) An elderly person relying upon an uncured or incurable deceptive act, including an act related to hypnotism, may bring an action to recover treble damages, if appropriate.
    (j) An offer to cure is:
        (1) not admissible as evidence in a proceeding initiated under this section unless the offer to cure is delivered by a supplier to the consumer or a representative of the consumer before the supplier files the supplier's initial response to a complaint; and
        (2) only admissible as evidence in a proceeding initiated under this section to prove that a supplier is not liable for attorney's fees under subsection (k).
If the offer to cure is timely delivered by the supplier, the supplier may submit the offer to cure as evidence to prove in the proceeding in accordance with the Indiana Rules of Trial Procedure that the supplier made an offer to cure.
    (k) A supplier may not be held liable for the attorney's fees and court costs of the consumer that are incurred following the timely

delivery of an offer to cure as described in subsection (j) unless the actual damages awarded, not including attorney's fees and costs, exceed the value of the offer to cure.
    (l) If a court finds that a person has knowingly violated section 3(a)(20) of this chapter, the attorney general, in an action under subsection (c), may recover from the person on behalf of the state a civil penalty not exceeding one thousand dollars ($1,000) per consumer. In determining the amount of the civil penalty in any action by the attorney general under this subsection, the court shall consider, among other relevant factors, the frequency and persistence of noncompliance by the debt collector, the nature of the noncompliance, and the extent to which the noncompliance was intentional. A person may not be held liable in any action by the attorney general for a violation of section 3(a)(20) of this chapter if the person shows by a preponderance of evidence that the violation was not intentional and resulted from a bona fide error, notwithstanding the maintenance of procedures reasonably adapted to avoid the error. A person may not be held liable in any action for a violation of this chapter for contacting a person other than the debtor, if the contact is made in compliance with the Fair Debt Collection Practices Act.

SOURCE: IC 25-1-1.1-3; (13)HB1524.1.9. -->     SECTION 9. IC 25-1-1.1-3, AS AMENDED BY P.L.78-2012, SECTION 8, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 3. A board, a commission, or a committee shall revoke or suspend a license or certificate issued under this title by the board, the commission, or the committee if the individual who holds the license or certificate is convicted of any of the following:
        (1) Dealing in or manufacturing cocaine or a narcotic drug under IC 35-48-4-1.
        (2) Dealing in methamphetamine under IC 35-48-4-1.1.
        (3) Dealing in a schedule I, II, or III controlled substance under IC 35-48-4-2.
        (4) Dealing in a schedule IV controlled substance under IC 35-48-4-3.
        (5) Dealing in a schedule V controlled substance under IC 35-48-4-4.
        (6) Dealing in a substance represented to be a controlled substance under IC 35-48-4-4.5.
        (7) Knowingly or intentionally manufacturing, advertising, distributing, or possessing with intent to manufacture, advertise, or distribute a substance represented to be a controlled substance under IC 35-48-4-4.6.
        (8) Dealing in a counterfeit substance under IC 35-48-4-5.
        (9) Dealing in marijuana, hash oil, hashish, or salvia or a synthetic drug under IC 35-48-4-10(b).
         (10) Dealing in a synthetic drug or synthetic drug lookalike substance under IC 35-48-4-10.5.
        (10) (11) Conspiracy under IC 35-41-5-2 to commit an offense listed in subdivisions (1) through (9) this section.
        (11) (12) Attempt under IC 35-41-5-1 to commit an offense listed in subdivisions (1) through (9) this section.
        (12) (13) An offense in any other jurisdiction in which the elements of the offense for which the conviction was entered are substantially similar to the elements of an offense described under subdivisions (1) through (11) in this section.
        (13) (14) A violation of any federal or state drug law or rule related to wholesale legend drug distributors licensed under IC 25-26-14.
SOURCE: IC 25-26-13-4.1; (13)HB1524.1.10. -->     SECTION 10. IC 25-26-13-4.1, AS ADDED BY P.L.78-2012, SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 4.1. (a) The board may adopt an emergency rule to declare that a substance is a synthetic drug.
    (b) The board may, on its own initiative or under a written request from the state police department, the United States Drug Enforcement Administration, or a poison control center, adopt an emergency rule declaring a substance to be a synthetic drug if the board finds that the substance:
        (1) has been scheduled or emergency scheduled by the United States Drug Enforcement Administration; or
        (2) has been scheduled, emergency scheduled, or criminalized by another state; or
        (3) has:
            (A) a high potential for abuse; and
            (B) no accepted medical use in treatment in the United States or lacks accepted safety for use in treatment under medical supervision.
    (c) In making its determination under subsection (b)(3), the board shall consider the following factors relating to the substance:
        (1) The actual or relative potential for abuse.
        (2) Scientific evidence of the substance's pharmacological effect, if known.
        (3) The state of current scientific knowledge regarding the substance.
        (4) The history and current pattern of abuse of the substance.
        (5) The scope, duration, and significance of abuse of the

substance.
        (6) The degree of risk to the public health.
        (7) The psychic or psychological dependence liability of the substance.

    (c) (d) A rule adopted under this section becomes effective thirty (30) days after it is filed with the publisher under IC 4-22-2-37.1.
    (d) (e) A rule adopted under this section expires on June 30 of the year following the year in which it is filed with the publisher under IC 4-22-2-37.1.
    (e) (f) The board may readopt under this section an emergency rule that has expired.

SOURCE: IC 32-30-8-2; (13)HB1524.1.11. -->     SECTION 11. IC 32-30-8-2, AS AMENDED BY P.L.87-2005, SECTION 38, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 2. (a) Except as provided in subsection (d), as used in this chapter, "property" means a house, a building, a mobile home, or an apartment that is leased for residential or commercial purposes.
    (b) The term includes:
        (1) an entire building or complex of buildings; or
        (2) a mobile home community;
and all real property of any nature appurtenant to and used in connection with the house, building, mobile home, or apartment, including all individual rental units and common areas.
    (c) The term does not include a hotel, motel, or other guest house, part of which is rented to a transient guest.
     (d) For actions brought by the attorney general in relation to the sale or solicited sale of a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5), "property" means a house, a building, a mobile home, or an apartment that is owned or leased for commercial or residential purposes. The term includes all real property of any nature appurtenant to and used in connection with the house, building, mobile home, or apartment.
SOURCE: IC 32-30-8-4; (13)HB1524.1.12. -->     SECTION 12. IC 32-30-8-4 IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 4. An action to abate a nuisance under this chapter may be initiated by any of the following:
        (1) The prosecuting attorney of the circuit where the nuisance is located.
        (2) The corporation counsel or city attorney of a city in which a nuisance is located.
        (3) An attorney representing a county in which a nuisance is

located.
        (4) The property owner.
         (5) The attorney general.

SOURCE: IC 32-30-8-10.5; (13)HB1524.1.13. -->     SECTION 13. IC 32-30-8-10.5 IS ADDED TO THE INDIANA CODE AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 10.5. In addition to the remedies and penalties specified in sections 10, 11, 12, and 13 of this chapter, the court may do any of the following in an action brought under this chapter concerning the sale or solicited sale of a synthetic drug (as defined in IC 35-31.5-2-321) or a synthetic drug lookalike substance (as defined in IC 35-31.5-2-321.5):
        (1) Issue a restraining order against the person subject to IC 32-30-7-9 and IC 32-30-7-13.
        (2) Issue a preliminary injunction, temporary forfeiture, or closure order pending final decision on a permanent injunction subject to IC 32-30-7-12.
        (3) Issue an order of abatement subject to IC 32-30-7-22.

SOURCE: IC 34-24-1-1; (13)HB1524.1.14. -->     SECTION 14. IC 34-24-1-1, AS AMENDED BY P.L.125-2012, SECTION 411, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 1. (a) The following may be seized:
        (1) All vehicles (as defined by IC 35-31.5-2-346), if they are used or are intended for use by the person or persons in possession of them to transport or in any manner to facilitate the transportation of the following:
            (A) A controlled substance for the purpose of committing, attempting to commit, or conspiring to commit any of the following:
                (i) Dealing in or manufacturing cocaine or a narcotic drug (IC 35-48-4-1).
                (ii) Dealing in methamphetamine (IC 35-48-4-1.1).
                (iii) Dealing in a schedule I, II, or III controlled substance (IC 35-48-4-2).
                (iv) Dealing in a schedule IV controlled substance (IC 35-48-4-3).
                (v) Dealing in a schedule V controlled substance (IC 35-48-4-4).
                (vi) Dealing in a counterfeit substance (IC 35-48-4-5).
                (vii) Possession of cocaine or a narcotic drug (IC 35-48-4-6).
                (viii) Possession of methamphetamine (IC 35-48-4-6.1).
                (ix) Dealing in paraphernalia (IC 35-48-4-8.5).
                (x) Dealing in marijuana, hash oil, hashish, or salvia or a

synthetic cannabinoid (IC 35-48-4-10).
                 (xi) Dealing in a synthetic drug or synthetic drug lookalike substance (IC 35-48-4-10.5).
            (B) Any stolen (IC 35-43-4-2) or converted property (IC 35-43-4-3) if the retail or repurchase value of that property is one hundred dollars ($100) or more.
            (C) Any hazardous waste in violation of IC 13-30-10-1.5.
            (D) A bomb (as defined in IC 35-31.5-2-31) or weapon of mass destruction (as defined in IC 35-31.5-2-354) used to commit, used in an attempt to commit, or used in a conspiracy to commit an offense under IC 35-47 as part of or in furtherance of an act of terrorism (as defined by IC 35-31.5-2-329).
        (2) All money, negotiable instruments, securities, weapons, communications devices, or any property used to commit, used in an attempt to commit, or used in a conspiracy to commit an offense under IC 35-47 as part of or in furtherance of an act of terrorism or commonly used as consideration for a violation of IC 35-48-4 (other than items subject to forfeiture under IC 16-42-20-5 or IC 16-6-8.5-5.1 before its repeal):
            (A) furnished or intended to be furnished by any person in exchange for an act that is in violation of a criminal statute;
            (B) used to facilitate any violation of a criminal statute; or
            (C) traceable as proceeds of the violation of a criminal statute.
        (3) Any portion of real or personal property purchased with money that is traceable as a proceed of a violation of a criminal statute.
        (4) A vehicle that is used by a person to:
            (A) commit, attempt to commit, or conspire to commit;
            (B) facilitate the commission of; or
            (C) escape from the commission of;
        murder (IC 35-42-1-1), kidnapping (IC 35-42-3-2), criminal confinement (IC 35-42-3-3), rape (IC 35-42-4-1), child molesting (IC 35-42-4-3), or child exploitation (IC 35-42-4-4), or an offense under IC 35-47 as part of or in furtherance of an act of terrorism.
        (5) Real property owned by a person who uses it to commit any of the following as a Class A felony, a Class B felony, or a Class C felony:
            (A) Dealing in or manufacturing cocaine or a narcotic drug (IC 35-48-4-1).
            (B) Dealing in methamphetamine (IC 35-48-4-1.1).
            (C) Dealing in a schedule I, II, or III controlled substance

(IC 35-48-4-2).
            (D) Dealing in a schedule IV controlled substance (IC 35-48-4-3).
            (E) Dealing in marijuana, hash oil, hashish, or salvia or a synthetic cannabinoid (IC 35-48-4-10).
             (F) Dealing in a synthetic drug or synthetic drug lookalike substance (IC 35-48-4-10.5).
        (6) Equipment and recordings used by a person to commit fraud under IC 35-43-5-4(10).
        (7) Recordings sold, rented, transported, or possessed by a person in violation of IC 24-4-10.
        (8) Property (as defined by IC 35-31.5-2-253) or an enterprise (as defined by IC 35-45-6-1) that is the object of a corrupt business influence violation (IC 35-45-6-2).
        (9) Unlawful telecommunications devices (as defined in IC 35-45-13-6) and plans, instructions, or publications used to commit an offense under IC 35-45-13.
        (10) Any equipment, including computer equipment and cellular telephones, used for or intended for use in preparing, photographing, recording, videotaping, digitizing, printing, copying, or disseminating matter in violation of IC 35-42-4.
        (11) Destructive devices used, possessed, transported, or sold in violation of IC 35-47.5.
        (12) Tobacco products that are sold in violation of IC 24-3-5, tobacco products that a person attempts to sell in violation of IC 24-3-5, and other personal property owned and used by a person to facilitate a violation of IC 24-3-5.
        (13) Property used by a person to commit counterfeiting or forgery in violation of IC 35-43-5-2.
        (14) After December 31, 2005, if a person is convicted of an offense specified in IC 25-26-14-26(b) or IC 35-43-10, the following real or personal property:
            (A) Property used or intended to be used to commit, facilitate, or promote the commission of the offense.
            (B) Property constituting, derived from, or traceable to the gross proceeds that the person obtained directly or indirectly as a result of the offense.
        (15) Except as provided in subsection (e), a vehicle used by a person who operates the vehicle:
            (A) while intoxicated, in violation of IC 9-30-5-1 through IC 9-30-5-5, if in the previous five (5) years the person has two (2) or more prior unrelated convictions:


                (i) for operating a motor vehicle while intoxicated in violation of IC 9-30-5-1 through IC 9-30-5-5; or
                (ii) for an offense that is substantially similar to IC 9-30-5-1 through IC 9-30-5-5 in another jurisdiction; or
            (B) on a highway while the person's driving privileges are suspended in violation of IC 9-24-19-2 through IC 9-24-19-4, if in the previous five (5) years the person has two (2) or more prior unrelated convictions:
                (i) for operating a vehicle while intoxicated in violation of IC 9-30-5-1 through IC 9-30-5-5; or
                (ii) for an offense that is substantially similar to IC 9-30-5-1 through IC 9-30-5-5 in another jurisdiction.
        If a court orders the seizure of a vehicle under this subdivision, the court shall transmit an order to the bureau of motor vehicles recommending that the bureau not permit a vehicle to be registered in the name of the person whose vehicle was seized until the person possesses a current driving license (as defined in IC 9-13-2-41).
        (16) The following real or personal property:
            (A) Property used or intended to be used to commit, facilitate, or promote the commission of an offense specified in IC 23-14-48-9, IC 30-2-9-7(b), IC 30-2-10-9(b), or IC 30-2-13-38(f).
            (B) Property constituting, derived from, or traceable to the gross proceeds that a person obtains directly or indirectly as a result of an offense specified in IC 23-14-48-9, IC 30-2-9-7(b), IC 30-2-10-9(b), or IC 30-2-13-38(f).
    (b) A vehicle used by any person as a common or contract carrier in the transaction of business as a common or contract carrier is not subject to seizure under this section, unless it can be proven by a preponderance of the evidence that the owner of the vehicle knowingly permitted the vehicle to be used to engage in conduct that subjects it to seizure under subsection (a).
    (c) Equipment under subsection (a)(10) may not be seized unless it can be proven by a preponderance of the evidence that the owner of the equipment knowingly permitted the equipment to be used to engage in conduct that subjects it to seizure under subsection (a)(10).
    (d) Money, negotiable instruments, securities, weapons, communications devices, or any property commonly used as consideration for a violation of IC 35-48-4 found near or on a person who is committing, attempting to commit, or conspiring to commit any of the following offenses shall be admitted into evidence in an action

under this chapter as prima facie evidence that the money, negotiable instrument, security, or other thing of value is property that has been used or was to have been used to facilitate the violation of a criminal statute or is the proceeds of the violation of a criminal statute:
        (1) IC 35-48-4-1 (dealing in or manufacturing cocaine or a narcotic drug).
        (2) IC 35-48-4-1.1 (dealing in methamphetamine).
        (3) IC 35-48-4-2 (dealing in a schedule I, II, or III controlled substance).
        (4) IC 35-48-4-3 (dealing in a schedule IV controlled substance).
        (5) IC 35-48-4-4 (dealing in a schedule V controlled substance) as a Class B felony.
        (6) IC 35-48-4-6 (possession of cocaine or a narcotic drug) as a Class A felony, Class B felony, or Class C felony.
        (7) IC 35-48-4-6.1 (possession of methamphetamine) as a Class A felony, Class B felony, or Class C felony.
        (8) IC 35-48-4-10 (dealing in marijuana, hash oil, hashish, or salvia) or a synthetic cannabinoid) as a Class C felony.
         (9) IC 35-48-4-10.5 (dealing in a synthetic drug or synthetic drug lookalike substance) as a Class C felony or Class D felony.
    (e) A vehicle operated by a person who is not:
        (1) an owner of the vehicle; or
        (2) the spouse of the person who owns the vehicle;
is not subject to seizure under subsection (a)(15) unless it can be proven by a preponderance of the evidence that the owner of the vehicle knowingly permitted the vehicle to be used to engage in conduct that subjects it to seizure under subsection (a)(15).

SOURCE: IC 35-31.5-2-321; (13)HB1524.1.15. -->     SECTION 15. IC 35-31.5-2-321, AS ADDED BY P.L.114-2012, SECTION 67, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 321. "Synthetic drug" means:
        (1) a substance containing one (1) or more of the following chemical compounds, including an analog of the compound:
            (A) JWH-015 ((2-Methyl-1-propyl-1H-
            indol-3-yl)-1-naphthalenylmethanone).
            (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
            (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
            (D) JWH-073
            (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
            (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol- 3-yl)methanone).
            (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
            (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)- naphthalen-1-yl-methanone).
            (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
            (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
            (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
            (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)-
            6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
            (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl- 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo [c]chromen-1-ol).
            (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4- (2-methyloctan- 2-yl)phenyl]-
            7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
            (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6- (1-methylethenyl)-2 -cyclohexen-1-yl]-5 -pentyl-2,5-cyclohexadiene-1,4-dione).
            (O) CP 55,940
            (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]- 5- (2-methyloctan-2-yl)phenol).
            (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5- (2-methyloctan-2-yl)phenol) and its homologues, or
            2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
            phenol), where side chain n=5, and homologues where side chain n=4, 6, or 7.
            (Q) WIN 55212-2
            ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo [1,2,3-de)- 1,4- benzoxazin-
            6-yl]-1-napthalenylmethanone).
            (R) RCS-4 ((4-methoxyphenyl)
            (1-pentyl-1H-indol-3-yl)methanone).
            (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
            indol-3-yl)-2-(2-methoxyphenyl)ethanone).
            (T) 4-Methylmethcathinone. Other name: mephedrone.
            (U) 3,4-Methylenedioxymethcathinone. Other name: methylone.
            (V) Fluoromethcathinone.
            (W) 4-Methoxymethcathinone. Other name: methedrone.
            (X) 4-Ethylmethcathinone (4-EMC).
            (Y) Methylenedioxypyrovalerone. Other name: MDPV.
            (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
            (AA) JWH-098, or
            1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
            (BB) JWH-164, or
            1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
            (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
            (DD) JWH-201, or
            1-pentyl-3-(4-methoxyphenylacetyl)indole.
            (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
            (FF) AM-694, or
            1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
            (GG) CP 50,556-1, or
            [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1 -yl] acetate.
            (HH) Dimethylheptylpyran, or DMHP.
            (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
            (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
            (LL) 7-hydroxymitragynine.
            (MM) .-PPP [.-pyrrolidinopropiophenone].
            (NN) .-PVP (desmethylpyrovalerone).
            (OO) AM-251.
            (PP) AM-1241.
            (QQ) AM-2201.
            (RR) AM-2233.
            (SS) Buphedrone.
            (TT) Butylone.
            (UU) CP-47,497-C7.
            (VV) CP-47,497-C8.
            (WW) Desoxypipradol.
            (XX) Ethylone.
            (YY) Eutylone.
            (ZZ) Flephedrone.
            (AAA) JWH-011.
            (BBB) JWH-020.
            (CCC) JWH-022.
            (DDD) JWH-030.
            (EEE) JWH-182.
            (FFF) JWH-302.
            (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
            (HHH) Mitragynine.
            (III) Naphyrone.
            (JJJ) Pentedrone.
            (LLL) Pentylone.
            (MMM) Methoxetamine
            [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
            (NNN) A796,260
            [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]- (2,2,3,3-tetramethylcyclopropyl)methanone].
            (OOO) AB-001[(1s,3s)-admantan-1-yl) (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3- (1-adamantoyl)indole].
            (PPP) AM-356 [Methanandamide].
            (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]- 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or [(1-[(N-methylpiperindin-2- yl)Methyl]-3-(Adamant-1-oyl)indole)].
            (RRR) AM 2233 Azepane isomer [(2-iodophenyl) (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
            (SSS) CB-13 [1-Naphthalenyl [4-(pentyoxy)- 1-naphthalenyl]methanone].
            (TTT) UR-144 [(1-pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl)-methanone].
            (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)- cyclohexylcarbamate].
            (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid, cyclohexyl ester].
            (WWW) URB 754 [6-methyl-2-[(4-methylphenyl) amino]-1-benzoxazin-4-one].
            (XXX) XLR-11 or 5-fluoro UR-144 (1-(5-fluoropentyl)-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl)methanone].

             (YYY) AKB48 (Other names include: N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide; 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
            carboxamide).
            (ZZZ) 25I-NBOMe (Other names include: 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
            benzeneethanamine); 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
            methyl]ethanamine).
            (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe; 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
            phenethylamine).
            (BBBB) 2NE-1 (Other names include: 1-Pentyl-3- (1-adamantylamido)indole).
            (CCCC) STS-135 (Other names include: N-Adamantyl-1-fluoropentylindole-3- carboxamide (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H- indole-3-carboxamide).

        (2) Any compound structurally derived from 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
        (3) Any compound structurally derived from 3-(1-naphthoyl) pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
        (4) Any compound structurally derived from 1-(1-naphthylmethyl)indene by substitution at the 3-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
        (5) Any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
        (6) Any compound structurally derived from 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not substituted in the cyclohexyl ring to any extent.
        (7) Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.
        (8) Any compound, except bupropion or a compound listed under a different schedule, structurally derived from 2-aminopropan-1-one by substitution at the 1-position with either phenyl, naphthyl, or thiophene ring systems, whether or not the compound is further modified:
            (A) by substitution in the ring system to any extent with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide substituents, whether or not further substituted in the ring system by one or more other univalent substituents;
            (B) by substitution at the 3-position with an acyclic alkyl substituent;
            (C) by substitution at the 2-amino nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; or
            (D) by inclusion of the 2-amino nitrogen atom in a cyclic structure.
         (9) Any compound structurally derived from 3-tetramethyl cyclopropanoylindole with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl, 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropyl ring to any extent.
         (10) Any compound containing a N-(1-adamantyl)-

1H-indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted at the nitrogen atom of the carboxamide to any extent, whether or not further substituted in the indazole ring to any extent, and whether or not further substituted on the adamantyl ring system to any extent. An example of this structural class includes AKB48.
         (11) Any compound containing a N-(1-adamantyl)- 1H-indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl group, whether or not further substituted at the nitrogen atom of the carboxamide to any extent, whether or not further substituted in the indole ring to any extent, and whether or not further substituted on the adamantyl ring system to any extent. An example of this structural class includes STS-135.

        (9) (12) Any compound determined to be a synthetic drug by rule adopted under IC 25-26-13-4.1.
SOURCE: IC 35-31.5-2-321.5; (13)HB1524.1.16. -->     SECTION 16. IC 35-31.5-2-321.5 IS ADDED TO THE INDIANA CODE AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 321.5. (a) "Synthetic drug lookalike substance", except as provided in subsection (b), means one (1) or more of the following:
        (1) A substance that a reasonable person would believe is a synthetic drug.
        (2) A substance that a reasonable person would believe is being purchased or sold as a synthetic drug.
        (3) A substance that a person knows or should have known was intended to be consumed, and that consumption was intended to cause or simulate intoxication.
    (b) The term "synthetic drug lookalike substance" does not include the following:
        (1) Food and food ingredients (as defined in IC 6-2.5-1-20).
        (2) Alcohol (as defined in IC 7.1-1-3-4).
        (3) A legend drug (as defined in IC 16-18-2-199).
        (4) Tobacco (as defined in IC 6-2.5-1-28).
        (5) A dietary supplement (as defined in IC 6-2.5-1-16).

SOURCE: IC 35-45-6-1; (13)HB1524.1.17. -->     SECTION 17. IC 35-45-6-1, AS AMENDED BY P.L.126-2012, SECTION 56, AND AS AMENDED BY P.L.149-2012, SECTION 19, IS CORRECTED AND AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 1. (a) The definitions in this section apply throughout this chapter.
    (b) "Documentary material" means any document, drawing, photograph, recording, or other tangible item containing compiled data from which information can be either obtained or translated into a usable form.
    (c) "Enterprise" means:
        (1) a sole proprietorship, corporation, limited liability company, partnership, business trust, or governmental entity; or
        (2) a union, an association, or a group, whether a legal entity or merely associated in fact.
    (d) "Pattern of racketeering activity" means engaging in at least two (2) incidents of racketeering activity that have the same or similar intent, result, accomplice, victim, or method of commission, or that are otherwise interrelated by distinguishing characteristics that are not isolated incidents. However, the incidents are a pattern of racketeering activity only if at least one (1) of the incidents occurred after August 31, 1980, and if the last of the incidents occurred within five (5) years after a prior incident of racketeering activity.
    (e) "Racketeering activity" means to commit, to attempt to commit, to conspire to commit a violation of, or aiding and abetting in a violation of any of the following:
        (1) A provision of IC 23-19, or of a rule or order issued under IC 23-19.
        (2) A violation of IC 35-45-9.
        (3) A violation of IC 35-47.
        (4) A violation of IC 35-49-3.
        (5) Murder (IC 35-42-1-1).
        (6) Battery as a Class C felony (IC 35-42-2-1).
        (7) Kidnapping (IC 35-42-3-2).
        (8) Human and sexual trafficking crimes (IC 35-42-3.5).
        (9) Child exploitation (IC 35-42-4-4).
        (10) Robbery (IC 35-42-5-1).
        (11) Carjacking (IC 35-42-5-2).
        (12) Arson (IC 35-43-1-1).
        (13) Burglary (IC 35-43-2-1).
        (14) Theft (IC 35-43-4-2).
        (15) Receiving stolen property (IC 35-43-4-2).
        (16) Forgery (IC 35-43-5-2).
        (17) Fraud (IC 35-43-5-4(1) through IC 35-43-5-4(10)).
        (18) Bribery (IC 35-44-1-1). (IC 35-44.1-1-2).
        (19) Official misconduct (IC 35-44-1-2). (IC 35-44.1-1-1).
        (20) Conflict of interest (IC 35-44-1-3). (IC 35-44.1-1-4).
        (21) Perjury (IC 35-44-2-1). (IC 35-44.1-2-1).
        (22) Obstruction of justice (IC 35-44-3-4). (IC 35-44.1-2-2).
        (23) Intimidation (IC 35-45-2-1).
        (24) Promoting prostitution (IC 35-45-4-4).
        (25) Professional gambling (IC 35-45-5-3).
        (26) Maintaining a professional gambling site (IC 35-45-5-3.5(b)).
        (27) Promoting professional gambling (IC 35-45-5-4).
        (28) Dealing in or manufacturing cocaine or a narcotic drug (IC 35-48-4-1).
        (29) Dealing in or manufacturing methamphetamine (IC 35-48-4-1.1).
        (30) Dealing in a schedule I, II, or III controlled substance (IC 35-48-4-2).
        (31) Dealing in a schedule IV controlled substance (IC 35-48-4-3).
        (32) Dealing in a schedule V controlled substance (IC 35-48-4-4).
        (33) Dealing in marijuana, hash oil, hashish, salvia, or a synthetic cannabinoid (IC 35-48-4-10).
        (34) Money laundering (IC 35-45-15-5).
        (35) A violation of IC 35-47.5-5.
        (36) A violation of any of the following:
            (A) IC 23-14-48-9.
            (B) IC 30-2-9-7(b).
            (C) IC 30-2-10-9(b).
            (D) IC 30-2-13-38(f).
        (37) Practice of law by a person who is not an attorney (IC 33-43-2-1).
         (38) Dealing in a synthetic drug or synthetic drug lookalike substance (IC 35-48-4-10.5).
SOURCE: IC 35-46-9-2; (13)HB1524.1.18. -->     SECTION 18. IC 35-46-9-2, AS ADDED BY P.L.40-2012, SECTION 21, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 2. As used in this chapter, "intoxicated" means under the influence of:
        (1) alcohol;
        (2) a controlled substance;
        (3) any drug (as defined in IC 9-13-2-49.1) other than alcohol or a controlled substance; or
        (4) any combination of alcohol, controlled substances, or drugs; or
        (5) any other substance, not including food and food ingredients (as defined in IC 6-2.5-1-20), tobacco (as defined in IC 35-46-1-1.7), or a dietary supplement (as defined in IC 6-2.5-1-16);

so that there is an impaired condition of thought and action and the loss of normal control of an individual's faculties.
SOURCE: IC 35-48-2-4; (13)HB1524.1.19. -->     SECTION 19. IC 35-48-2-4, AS AMENDED BY P.L.114-2012, SECTION 144, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 4. (a) The controlled substances listed in this section are included in schedule I.
    (b) Opiates. Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
        Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- piperidinyl]-N-phenylacetamide) (9815)
        Acetylmethadol (9601)
        Allylprodine (9602)
        Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
        thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
        Alphacetylmethadol (9603)
        Alphameprodine (9604)
        Alphamethadol (9605)
        Alphamethylfentanyl (9814)
        Benzethidine (9606)
        Beta-hydroxy-3-methylfentanyl (9831). Other name: N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
        ]-N-phenylpropanamide
        Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
        phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
        Betacetylmethadol (9607)
        Betameprodine (9608)
        Betamethadol (9609)
        Betaprodine (9611)
        Clonitazene (9612)
        Dextromoramide (9613)
        Diampromide (9615)
        Diethylthiambutene (9616)
        Difenoxin (9168)
        Dimenoxadol (9617)
        Dimepheptanol (9618)
        Dimethylthiambutene (9619)
        Dioxaphetyl butyrate (9621)
        Dipipanone (9622)
        Ethylmethylthiambutene (9623)
        Etonitazene (9624)
        Etoxeridine (9625)
        Furethidine (9626)
        Hydroxypethidine (9627)
        Ketobemidone (9628)
        Levomoramide (9629)
        Levophenacylmorphan (9631)
        3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
        piperidyl]-N-phenyl-propanimide](9813)
        3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4- piperidinyl]-N-phenylpropanamide) (9833)
        MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
        Morpheridine (9632)
        N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl), including any isomers, salts, or salts of isomers (9818)
        N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl), including any isomers, salts, or salts of isomers (9834)
        Noracymethadol (9633)
        Norlevorphanol (9634)
        Normethadone (9635)
        Norpipanone (9636)
        Para-fluorofentanyl (N-(4-fluorophenyl)-N-
        [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
        Phenadoxone (9637)
        Phenampromide (9638)
        Phenomorphan (9647)
        Phenoperidine (9641)
        PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
        Piritramide (9642)
        Proheptazine (9643)
        Properidine (9644)
        Propiram (9649)
        Racemoramide (9645)
        Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
        piperidinyl]-propanamide) (9835)
        Tilidine (9750)
        Trimeperidine (9646)
    (c) Opium derivatives. Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
        Acetorphine (9319)
        Acetyldihydrocodeine (9051)
        Benzylmorphine (9052)
        Codeine methylbromide (9070)
        Codeine-N-Oxide (9053)
        Cyprenorphine (9054)
        Desomorphine (9055)
        Dihydromorphine (9145)
        Drotebanol (9335)
        Etorphine (except hydrochloride salt) (9056)
        Heroin (9200)
        Hydromorphinol (9301)
        Methyldesorphine (9302)
        Methyldihydromorphine (9304)
        Morphine methylbromide (9305)
        Morphine methylsulfonate (9306)
        Morphine-N-Oxide (9307)
        Myrophine (9308)
        Nicocodeine (9309)
        Nicomorphine (9312)
        Normorphine (9313)
        Pholcodine (9314)
        Thebacon (9315)
    (d) Hallucinogenic substances. Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic, psychedelic, or psychogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted by rule of the board or unless listed in another schedule, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:
        (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:

TCPy.
        (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade or other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine; 4-Bromo-2, 5-DMA.
        (3) 4-Bromo-2, 5-dimethoxphenethylamine (7392). Some trade or other names:
        2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus.
        (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name: DOET.
        (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348). Other name: 2C-T-7.
        (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
        (7) 4-Methoxyamphetamine (7411). Some trade or other names: 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine; PMA.
        (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other Name: MMDA.
        (9) 5-Methoxy-N, N-diisopropyltryptamine, including any isomers, salts, or salts of isomers (7439). Other name: 5-MeO-DIPT.
        (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade and other names: 4-methyl-2,
        5-dimethoxy-a-methylphenethylamine; DOM; and STP.
        (11) 3, 4-methylenedioxy amphetamine (7400). Other name: MDA.
        (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other names: N-ethyl-alpha-methyl-3,4(methylenedioxy) phenethylamine; N-ethyl MDA; MDE; and MDEA.
        (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
        (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
        (15) Alpha-ethyltryptamine (7249). Some trade and other names: Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
        (16) Alpha-methyltryptamine (7432). Other name: AMT.
        (17) Bufotenine (7433). Some trade and other names: 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
        3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-dimethyltryptamine; mappine.
        (18) Diethyltryptamine (7434). Some trade or other names: N,

N-Diethyltryptamine; DET.
        (19) Dimethyltrytamine (7435). Dimethyltryptamine (7435). Some trade or other names: DMT.
        (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
        (21) Lysergic acid diethylamide (7315). Other name: LSD.
        (22) Marijuana (7360).
        (23) Mescaline (7381).
        (24) Parahexyl (7374). Some trade or other names: 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6, 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
        (25) Peyote (7415), including:
            (A) all parts of the plant that are classified botanically as lophophora williamsii lemaire, whether growing or not;
            (B) the seeds thereof;
            (C) any extract from any part of the plant; and
            (D) every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts.
        (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
        (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other names: N-hydroxy-alpha-methyl-3,4
        (methylenedioxy)phenethylamine; and N-hydroxy MDA.
        (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
        (29) Psilocybin (7437).
        (30) Psilocyn (7438).
        (31) Tetrahydrocannabinols (7370), including synthetic equivalents of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity such as:
            (A) .1 cis or trans tetrahydrocannabinol, and their optical isomers;
            (B) .6 cis or trans tetrahydrocannabinol, and their optical isomers; and
            (C) .3,4 cis or trans tetrahydrocannabinol, and their optical isomers.
        Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions are covered. Other name: THC.
        (32) Ethylamine analog of phencyclidine (7455). Some trade or

other names: N-Ethyl-1-phenylcyclohexylamine; (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl) ethylamine; cyclohexamine; PCE.
        (33) Pyrrolidine analog of phencyclidine (7458). Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy; PHP.
        (34) Thiophene analog of phencyclidine (7470). Some trade or other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl Analog of Phencyclidine; TPCP.
        (35) Synthetic drugs (as defined in IC 35-31.5-2-321).
        (36) Salvia divinorum or salvinorin A, including:
            (A) all parts of the plant that are classified botanically as salvia divinorum, whether growing or not;
            (B) the seeds of the plant;
            (C) any extract from any part of the plant; and
            (D) every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or extracts.
    (e) Depressants. Unless specifically excepted in a rule adopted by the board or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
        Gamma-hydroxybutyric acid (other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) (2010)
        Mecloqualone (2572)
        Methaqualone (2565)
    (f) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
        ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
        dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
        Aminorex (1585). Other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
        4,5-dihydro-5-phenyl-2-oxazolamine.
        Cathinone (1235). Some trade or other names: 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone; 2-aminopropiophenone; and norephedrone.
        Fenethylline (1503).


        N-Benzylpiperazine (7493). Other names: BZP; and 1-benzylpiperazine.
        N-ethylamphetamine (1475)
        Methcathinone (1237) Some other trade names: 2-Methylamino-1-Phenylpropan-I-one; Ephedrone; Monomethylpropion; UR 1431.
        N, N-dimethylamphetamine (1480). Other names: N, N-alpha-trimethyl-benzeneethanamine; and N, N-alpha-trimethylphenethylamine.
SOURCE: IC 35-48-4-10; (13)HB1524.1.20. -->     SECTION 20. IC 35-48-4-10, AS AMENDED BY P.L.78-2012, SECTION 14, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 10. (a) A person who:
        (1) knowingly or intentionally:
            (A) manufactures;
            (B) finances the manufacture of;
            (C) delivers; or
            (D) finances the delivery of;
        marijuana, hash oil, hashish, or salvia, or a synthetic drug, pure or adulterated; or
        (2) possesses, with intent to:
            (A) manufacture;
            (B) finance the manufacture of;
            (C) deliver; or
            (D) finance the delivery of;
        marijuana, hash oil, hashish, or salvia, or a synthetic drug, pure or adulterated;
commits dealing in marijuana, hash oil, hashish, or salvia, or a synthetic drug, a Class A misdemeanor, except as provided in subsection (b).
    (b) The offense is:
        (1) a Class D felony if:
            (A) the recipient or intended recipient is under eighteen (18) years of age;
            (B) the amount involved is
                (i) more than thirty (30) grams but less than ten (10) pounds of marijuana or more than two (2) grams but less than three hundred (300) grams of hash oil, hashish, or salvia; or
                (ii) more than two (2) grams of a synthetic drug; or
            (C) the person has a prior conviction of an offense involving marijuana, hash oil, hashish, or salvia; or a synthetic drug; and
        (2) a Class C felony if
            (A) the amount involved is ten (10) pounds or more of

marijuana or three hundred (300) or more grams of hash oil, hashish, or salvia, or the person delivered or financed the delivery of marijuana, hash oil, hashish, or salvia:
            (i) (A) on a school bus; or
            (ii) (B) in, on, or within one thousand (1,000) feet of, school property, a public park, a family housing complex, or a youth program center. or
            (B) the amount involved is more than two (2) grams of a synthetic drug and the person delivered or financed the delivery of the synthetic drug:
                (i) on a school bus; or
                (ii) in, on, or within one thousand (1,000) feet of school property, a public park, a family housing complex, or a youth program center.

SOURCE: IC 35-48-4-10.5; (13)HB1524.1.21. -->     SECTION 21. IC 35-48-4-10.5 IS ADDED TO THE INDIANA CODE AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE UPON PASSAGE]: Sec. 10.5. (a) A person who:
        (1) manufactures;
        (2) finances the manufacture of;
        (3) delivers;
        (4) finances the delivery of;
        (5) possesses, with intent to deliver; or
        (6) possesses, with intent to finance the delivery of;
a synthetic drug or a synthetic drug lookalike substance commits dealing in a synthetic drug or synthetic drug lookalike substance, a Class A infraction. However, the offense is a Class D felony if the offense is committed knowingly or intentionally and the person has a prior unrelated judgment or conviction under this subsection.

     (b) A person who:
        (1) knowingly or intentionally:
            (A) manufactures;
            (B) finances the manufacture of;
            (C) delivers; or
            (D) finances the delivery of;
        a synthetic drug or synthetic drug lookalike substance; or
        (2) possesses, with intent to:
            (A) manufacture;
            (B) finance the manufacture of;
            (C) deliver; or
            (D) finance the delivery of;
        a synthetic drug or synthetic drug lookalike substance;
commits dealing in a synthetic drug or synthetic drug lookalike

substance, a Class A misdemeanor, except as provided in subsection (c).
     (c) The offense in subsection (b) is:
        (1) a Class D felony if:
            (A) the recipient or intended recipient is less than eighteen (18) years of age;
            (B) the amount involved is more than two (2) grams; or
            (C) the person has a prior conviction of an offense involving a synthetic drug or synthetic drug lookalike substance; and
        (2) a Class C felony if the amount involved is more than two (2) grams and the person delivered or financed the delivery of the synthetic drug or synthetic drug lookalike substance:
            (A) on a school bus; or
            (B) in, on, or within one thousand (1,000) feet of, school property, a public park, a family housing complex, or a youth program center.
    (d) In determining whether a substance is a synthetic drug lookalike substance, the trier of fact may consider, in addition to other relevant factors, the following:
        (1) The overall appearance of the substance, including shape, color, size, markings or lack of markings, taste, consistency, or any other identifying physical characteristic of the substance.
        (2) A statement made by the owner or other person in control of the substance concerning the substance's nature, use, or effect.
        (3) A statement made by any person to the buyer or recipient of the substance suggesting or implying that the substance may be resold for profit.
        (4) Whether:
            (A) the distribution included an exchange of, or demand for, money or other property as consideration;
            (B) the amount of the consideration was substantially greater than the reasonable retail market value of the substance;
            (C) the substance is expressly or impliedly represented to be a synthetic drug; and
            (D) the substance is distributed under circumstances that would lead a reasonable person to believe that the substance is a controlled substance.
    (e) In addition to a criminal or civil penalty imposed for a

violation of this section, if the court finds that a person has violated this section and the violation involved the sale of or offer to sell, in the normal course of business, a synthetic drug or a synthetic drug lookalike substance by a retail merchant in a place of business for which the retail merchant has been issued a registered retail merchant certificate, the court shall recommend the suspension of the registered retail merchant certificate for the place of business for one (1) year.
    (f) The department of state revenue shall suspend the registered retail merchant certificate of a retail merchant in accordance with the recommendation of the court. Whenever the department of state revenue is required to suspend a retail merchant's registered retail merchant certificate under this section, the department shall immediately mail a notice to the retail merchant's address that must state that the retail merchant's registered retail merchant certificate will be suspended for one (1) year, commencing five (5) days after the date of the notice.

SOURCE: ; (13)HB1524.1.22. -->     SECTION 22. An emergency is declared for this act.